In it’s first five years in existence, CIRM has awarded almost $1.2 billion for stem cell research in the state of California in the form of just over 400 grants. To give you some perspective on that amount of research funding, let’s compare this CIRM funding to NIH funding for stem cell research across the …
Part of the Republican’s so-called “Pledge to America” was to cut $100 billion from the federal budget. Even though fiscal year 2011 is already almost half over, Republicans driven by Tea Party Mad Hatters have proposed to cut $100 billion from the budget for this year, increasing their proposed cuts of many programs including deeper …
Each year brings more evidence that what causes many cancers is a case of biological betrayal on the part of stem cells via cancer stem cells. I have blogged before about the potential for stem cell-based regenerative medicine therapies to aid cancer patients. I have also written before about my own experiences as a cancer …
Everyone has been understandably stressed about how the ongoing federal legislative process might effect funding for research including stem cell research. Particularly worrisome was the proposal from the new Republican-controlled House of Representatives to cut $100 billion from the budget. Today brought news (reported at one of my favorite blogs, The Great Beyond) that in …
Great news: Initial GOP list of proposed cuts mostly spares NIH! Read More »
What’s going on these days with biotech companies working on stem cell-based products? Geron’s and Advanced Cell Technology (ACT)’s FDA-approved trials presumably continue. As expected, no news yet. It’s too soon. Two important questions regarding both these companies are (1) did they apply for CIRM funding and (2) if so, how did the review process …
Stem cell biotech updates: Geron, ACT, Neuralstem, Pfizer Read More »
It’s been more than 4 years since Shinya Yamanaka published the remarkable finding that his lab could transform or “reprogram” regular cells called fibroblasts into a very unique state that was quite similar to that of embryonic stem cells (ESC). Yamanaka called these new cells “iPS cells” for induced pluripotent stem cells. Since that time, …
My post yesterday on the problems with the current system of stem cell funding generated a lot of interest from readers– more than a dozen left comments. Many of the comments were insightful even if readers disagreed on certain points. David Jensen also posted on an interesting piece on this issue in response to our …
Trends in Stem Cell Research Funding: where do we go from here? Read More »
Great ideas are the foundation of science, but funding makes great ideas become realities and a monopoly on funding hurts science. UPDATE: NIH data backs up our conclusions: overfunding wastes precious resources–give the money to smaller labs. Arguably the key driver of the exciting progress in stem cell research is funding. With the stakes so …
Stem cell monopoly: do not pass go, do not collect $200,000 Read More »
Reportedly, House Republicans are proposing a continuing resolution (CR) to fund the rest of FY2011 at 2008 funding levels. To achieve such an end, the Republicans would have to invoke serious cuts through the federal budget. Not only would such cuts likely damage the U.S. economy, but also they would have major other negative consequences. …
Today is New Year’s Day for the Chinese New Year. Happy New Year! On the Chinese Calendar it is year 4708 instead of 2011. I hope year 4708 is a good one for you and your family. Today being Chinese New Year has got me thinking about how the Chinese view stem cell research. My …
Happy Chinese New Year, Year 4708. China and Stem Cells Read More »